CRSP
Crispr Therapeutics AG
53.40$
+5.8%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +51.3% | +15.3% | +32.5% | -33.4% | +1,254.2% | -95.8% | -19.9% | -48.3% | -79.6% | +185.2% | -3.0% | +66,544.0% | -63.7% | -99.8% | -72.0% | +236.4% | +150.0% | -45.4% | +445,544.6% | -100.0% | +3,820.7% | -98.6% | -11.2% | -40.5% | -93.6% | +1,666,566.7% | -30.0% | -100.0% | – | -99.7% | +2.6% | +16.4% | +5,714.0% | -97.5% | +3.1% | -0.3% | -2.8% | +68.8% | +598.3% | – | |
| – | +29.2% | -4.9% | +15.6% | +4.2% | +12.2% | -2.6% | +31.3% | +55.3% | -27.7% | +0.2% | +37.0% | +44.8% | -14.8% | +11.1% | +9.6% | +19.6% | +16.0% | -75.8% | +35.1% | -16.6% | +500.6% | -77.3% | +10.7% | +14.6% | -82.4% | +518.4% | +5.8% | -47.5% | -14.6% | +159.0% | +10.0% | -72.0% | -74.0% | +1,285.4% | -13.5% | +30.0% | -8.2% | -15.4% | -11.3% | – | |
| – | – | – | – | – | – | -247.7% | – | – | – | – | – | – | -81.7% | -291.2% | – | – | – | – | – | -102.5% | – | – | – | – | – | – | -56.1% | -192.3% | – | -128.5% | – | – | – | -261.8% | – | – | – | – | – | – | |
| – | +29.2% | -4.9% | +15.6% | +4.2% | +12.2% | -2.6% | +31.3% | +55.3% | -27.7% | +17.4% | +16.9% | +44.8% | -14.8% | +11.1% | +9.6% | +19.6% | +16.0% | -14.3% | +16.6% | +1.4% | +23.5% | +14.7% | +4.2% | -5.4% | -11.2% | -3.5% | +1.6% | -10.7% | +4.9% | -25.0% | +5.6% | +2.7% | +6.2% | -11.8% | -9.9% | -9.8% | +32.2% | -11.9% | -5.3% | – | |
| – | +194.2% | -28.5% | -10.1% | +4.4% | +39.6% | -22.0% | +44.2% | -20.1% | +62.6% | -9.8% | +5.6% | -1.6% | +11.3% | +13.2% | +9.2% | +0.9% | +19.6% | -4.8% | +17.5% | -17.7% | -0.1% | +18.3% | -6.2% | +2.8% | -21.6% | +5.6% | -14.9% | -3.9% | -9.9% | +8.9% | +8.5% | -10.6% | +4.0% | +6.5% | -2.0% | -10.5% | +8.7% | -6.6% | +2.2% | – | |
| – | +71.1% | -15.2% | +6.1% | +4.3% | +20.8% | -9.6% | +35.3% | +30.3% | -9.3% | +7.5% | +13.4% | +31.6% | -76.3% | +13.2% | +9.2% | +0.9% | +19.6% | +267.9% | +16.7% | -3.5% | -77.8% | +514.5% | +2.7% | -3.9% | -13.2% | -1.9% | -1.4% | -9.6% | +1.3% | -19.1% | +6.2% | 0.0% | +5.1% | -7.8% | -8.2% | -18.9% | +41.0% | -15.4% | -1.3% | – | |
| – | – | – | – | – | – | -2,877.5% | – | – | – | – | – | – | -92.1% | -770.0% | – | – | – | – | – | -116.9% | – | – | – | – | – | – | – | – | – | -302.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +2,878.8% | -32.8% | +138.7% | +2.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -221.1% | – | – | – | -5,138.2% | – | – | – | – | – | – | -78.0% | -327.0% | – | – | – | – | – | -116.7% | – | – | – | – | – | – | – | – | – | -229.3% | – | – | – | – | – | – | – | – | – | – | |
| – | +4,900.0% | -30.3% | +22.9% | +106.1% | -40.7% | -79.5% | +11.6% | +42.7% | +70.8% | -63.7% | +0.0% | +222.4% | -98.5% | +9,325.0% | +0.5% | -47.2% | -26.5% | +291.2% | +620.5% | -114.4% | – | +60.1% | +69.6% | -109.4% | – | – | -30.1% | -55.4% | -43.4% | +210.7% | +77.8% | -31.9% | -20.1% | +58.4% | +16.5% | -52.1% | -0.8% | +36.6% | +14.4% | – | |
| – | – | -225.6% | – | – | – | -20,170.9% | – | – | – | – | – | – | -77.9% | -328.3% | – | – | – | – | – | -116.7% | – | – | – | – | – | – | – | – | – | -230.5% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -1,571.9% | – | – | – | – | – | – | -91.2% | -675.9% | – | – | – | – | – | -116.0% | – | – | – | – | – | – | – | – | – | -217.5% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.